2 cheap shares I’d buy in July

These two cheap shares, one well known and one more under the radar, could be set for share price growth, Andy Ross believes.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

These two cheap shares, one well known and one a bit more under the radar, could have strong share price growth in July and beyond.

A cheap insurance share

The first stock I’m looking at is Aviva (LSE: AV). It’s been going through a pretty aggressive turnaround with many international businesses sold off. Management is now focusing on the leaner (hopefully more profitable) business in the UK, Ireland and Canada.

On many value measures, Aviva looks cheap. Even after a solid share price rise over the last 12 months. The forward P/E is only eight. Although one caveat is that this makes it exactly the same as Legal & General, which is a broadly similar company, so that cheap P/E isn’t unusual.

The price-to-sales ratio is 0.35 and price-to-book is 0.84. With these ratios being well under one, it tells me as an investor that Aviva still appears to be a cheap share.

When I look at the recovery in the business, there’s the potential for strong dividend growth in the future. In 2021 the dividend is expected to grow by 75%. These figures are flattered by the 2019/20 financial year dividend cut. Nonetheless I think it’s a positive sign from the new Aviva.

In July the shares could rise in anticipation of August’s half year results, which should show Aviva’s progress and factor in the recovery from Covid-19. The big opportunity though, in my opinion, is to hold these shares longer term.

I’m considering adding Aviva to my own portfolio, based on the value and a growing dividend. 

Could the share price fall?

Of course the share price of Aviva, despite all the good work, could fall. The expected benefits of becoming smaller may not materialise long term. The UK economy could struggle and being more reliant on it, so in turn could Aviva.

Insurance is also a competitive market where it is hard to get customer loyalty, this could make growth harder to come by as could rules on penalising loyal customers, introduced in the UK recently. 

Low P/E + high yield = attractive?

Smiths News (LSE: SNWS) is a cheap share that’s less well known than bigger, consumer-facing company, Aviva. Yet for a value-inclined investor like me, it could have a lot of potential to provide useful returns within a balanced portfolio.

It’s a newspaper and magazine distributor, a business that may be in decline due to consumers switching to digital. However, the same has been the case for cigarettes for decades. Sometimes change is more incremental than the headlines would suggest. Good management can still eke out profits by focusing on costs and potentially new growth opportunities. 

When I look for cheap shares, Smiths News often comes up. That’s because the forward P/E is only four. That’s incredibly low. Together with a dividend yield of 5%, this appeals to both my value and income instincts.

However, as with any cheap share, there’s a risk it’s a value trap. So the shares could go even lower, even though they’re already priced very cheaply. Investors may fret about the decline of the newspaper business, which could hold back, or limit, any share price recovery.

Overall though, Smith’s News is a cheap share I’ll be keeping an eye on in July. I may even add it to my portfolio given the combination of low P/E and high dividend yield.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Andy Ross owns shares in Legal & General. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »